Pure Global
NCT06348628

Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease

Motivational Interviewing for Weight Loss in the Management of Non Alcoholic Fatty Liver Disease - A Randomized Controlled Trial
Madunil Anuk Niriella·ClinicalTrials.gov·behavioralRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention
Motivational Interview
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Madunil Anuk Niriella
Funder
University of Kelaniya
Location
Ragama, Sri Lanka
Timeline & enrollment
Phase
N/A
Start date
May 31, 2022
End date
Jul 01, 2025
Enrollment
231 participants
Primary outcome

Change in weight after 1 year compared to baseline,Change in Aspartate aminotransferase (AST) level and Alanine aminotransferase (ALT) level after 1 year compared to baseline,Change in platelet count after 1 year compared to baseline,Change in waist circumference and hip circumference after 1 year compared to baseline,Change in total fat percentage and visceral fat percentage after 1 year compared to baseline

Summary

The goal of this study is to assess if motivational counselling works to reduce the weight in
 participants with Non Alcoholic Fatty Liver Disease (NAFLD).

ICD-10 classifications
Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06348628
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06348628 through Pure Global AI's free database. This phase not specified trial is sponsored by Madunil Anuk Niriella and is currently Recruitment Completed. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 231 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.